As of June 2026, 41 paid clinical trials are recruiting for Lung disease in Kansas City, Kansas. Lung disease trials cover asthma biologics, COPD inhalers, antifibrotic therapies, CFTR modulators, and new lung cancer treatments across the full spectrum of chronic and acute respiratory illness. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Kansas City has approximately 477 recruiting research studies across a wide range of therapeutic areas. Kansas hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Researchers run research studies in Kansas City, KS at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Kansas Medical Center | Cystic Fibrosis, Stroke, Heart Failure | 190 |
| University of Kansas Cancer Center | Stage IV Lung Cancer AJCC v8, Acute Myeloid Leukemia, Metastatic Malignant Solid Neoplasm | 86 |
| The University of Kansas Medical Center | Hypersensitivity Pneumonitis, Interstitial Lung Disease, Pulmonary Fibrosis | 22 |
| Kansas University Medical Center | DM1, Myotonic Dystrophy 1, Acute GVHD | 13 |
| University of Kansas | Lung Diseases, Asthma, Asthma Attack | 9 |
| University of Kansas Hospital | Prostate Cancer, Atrial Fibrillation, Cardiovascular Disease and Lipoprotein(a) | 9 |
| The University of Kansas Hospital | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Carcinoma, Non-Small Cell Lung | 7 |
| University of Kansas Medical Center Research Institute | Gastroesophageal Junction Adenocarcinoma, Acute Myeloid Leukemia, COPD | 6 |
| The University of Kansas Cancer Center, Westwood Campus | NSCLC Stage IV, Locally Advanced Lung Carcinoma, Lung Cancer | 5 |
| University of Kansas Medical Center Research Institute, Inc. | Acute Myeloid Leukemia, Atrial Fibrillation, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | 5 |
| The University of Kansas Cancer Center | AML, AML With Mutated NPM1, Abdominal Neoplasm | 4 |
| University of Kansas Medical Center (KUMC) | DMD, Duchenne Muscular Dystrophy, Exon 44 | 4 |
| Clinical Trial Site | ATTR Amyloidosis, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, Transthyretin Amyloidosis With Cardiomyopathy | 3 |
| The University of Kansas Medical Center Medical Office Building | Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer, Esophageal Adenocarcinoma | 3 |
| University of Kansas Medical Center Research Institute, Inc | Idiopathic Pulmonary Fibrosis, Incontinence, Urinary, Overactive Bladder | 3 |
| Clinical & Translational Science Unit (CTSU) - Nephrology | Autosomal Dominant Polycystic Kidney Disease (ADPKD), Proteinuric Kidney Disease | 2 |
| Clinical Associates Midwest, LLC | Acute Treatment of Migraine, Pediatric Migraine | 2 |
| Clinical Study Site | Chronic Inflammatory Demyelinating Polyneuropathy, Multifocal Motor Neuropathy | 2 |
| Kansas City VA Medical Center | Cardiovascular Diseases, Cognitive Impairment, Mild, Dementia | 2 |
| Mobility and Falls Lab | Multiple Sclerosis, Parkinson's Disease (PD), Spasticity | 2 |
| The University of Kansas | Aortic Stenosis, Cystitis Recurrent, Recurrent UTIs | 2 |
| The University of Kansas Cancer Center - Westwood | Advanced NSCLC, Breast Cancer, Lung Cancer | 2 |
| The University of Kansas Health System | Acute Ischemic Stroke, Burns, Skin Graft Complications | 2 |
| Univeristy of Kansas Medical Center | Alzheimer Disease, FSHD, Healthy Aging | 2 |
| University of Kansas Cancer Center-West | Cardiotoxicity, HER2/Neu Positive, Metastatic Malignant Neoplasm in the Brain | 2 |
Recruiting trials in Kansas City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Kansas are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Kansas research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Kansas City from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 477 recruiting clinical trials in Kansas City, Kansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Kansas City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Kansas City include Cystic Fibrosis (11), Heart Failure (11), Acute Myeloid Leukemia (10), Stroke (9), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Kansas City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Kansas City include University of Kansas Medical Center, University of Kansas Cancer Center, The University of Kansas Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Kansas City are Cancer & tumors (134), Neurology & pain (53), Cardiovascular (38). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.